Leal-Cerro A - Search Results

1

Role of ketoconazole treatment in urinary-free cortisol-to-cortisone and tetrahydrocortisol-to-tetrahydrocortisone ratios in nonectopic Cushing's syndrome.

Stiefel P, García-Morillo JS, Jimenez L, Pamies E, Miranda ML, Carneado J, Villar J, Leal-Cerro A. Stiefel P, et al. Endocrine. 2002 Aug;18(3):279-84. doi: 10.1385/ENDO:18:3:279. Endocrine. 2002. PMID: 12450320

2

Arterial hypertension as a complication of prolonged ketoconazole treatment.

Leal-Cerro A, García-Luna PP, Villar J, Miranda ML, Pereira JL, Gomez-Pan A, Astorga R. Leal-Cerro A, et al. J Hypertens Suppl. 1989 Dec;7(6):S212-3. doi: 10.1097/00004872-198900076-00102. J Hypertens Suppl. 1989. PMID: 2632720

3

Description of a new quotient that may differentiate blood pressure profiles in essential versus Cushing's syndrome-related hypertension.

Stiefel P, Gimenez J, Miranda ML, Leal-Cerro A, Muñiz O, Pamies E, Martín-Sanz V, Villar J, Carneado J. Stiefel P, et al. J Endocrinol Invest. 1995 Nov;18(10):789-95. doi: 10.1007/BF03349812. J Endocrinol Invest. 1995. PMID: 8787956

4

The dispersion quotients: a new approach for evaluating the blood pressure profile in essential versus Cushing's syndrome hypertensive patients.

Gimenez J, Stiefel P, Miranda ML, Leal-Cerro A, Muñiz O, Pamies E, Martin-Sanz MV, Villar J, Carneado J. Gimenez J, et al. Ann N Y Acad Sci. 1996 Aug 15;783:321-3. doi: 10.1111/j.1749-6632.1996.tb26731.x. Ann N Y Acad Sci. 1996. PMID: 8853656 No abstract available.

5

Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome.

Leal-Cerro A, Venegas E, Garcia-Pesquera F, Jimenez LM, Astorga R, Casanueva FF, Dieguez C. Leal-Cerro A, et al. Clin Endocrinol (Oxf). 1998 Jan;48(1):117-21. doi: 10.1046/j.1365-2265.1998.00363.x. Clin Endocrinol (Oxf). 1998. PMID: 9509077

6

Acute pharmacological reduction of plasma free fatty acids enhances the growth hormone (GH)-releasing hormone-mediated GH secretion in patients with Cushing's syndrome.

Leal-Cerro A, Jimenez LM, Astorga R, Fernandez-Lopez I, Dieguez C, Casanueva FF. Leal-Cerro A, et al. J Clin Endocrinol Metab. 1997 Sep;82(9):3165-8. doi: 10.1210/jcem.82.9.4190. J Clin Endocrinol Metab. 1997. PMID: 9284763 Clinical Trial.

7

Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity.

Martinez-Brocca MA, Belda O, Parejo J, Jimenez L, del Valle A, Pereira JL, Garcia-Pesquera F, Astorga R, Leal-Cerro A, Garcia-Luna PP. Martinez-Brocca MA, et al. Obes Surg. 2007 May;17(5):649-57. doi: 10.1007/s11695-007-9109-z. Obes Surg. 2007. PMID: 17658025 Clinical Trial.

8

Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome.

Leal-Cerro A, Considine RV, Peino R, Venegas E, Astorga R, Casanueva FF, Dieguez C. Leal-Cerro A, et al. Horm Metab Res. 1996 Dec;28(12):711-3. doi: 10.1055/s-2007-979884. Horm Metab Res. 1996. PMID: 9013748

9

Budget impact of using midnight salivary cortisol in the diagnosis of hypercortisolism.

León-Justel A, Mangas MA, Infante Fontán R, Castro Luque J, Venegas Moreno E, Madrazo Atutxa A, Herrera del Rey T, Martin-Rodriguez JF, Soto-Moreno A, Leal-Cerro A. León-Justel A, et al. Clin Chim Acta. 2011 Nov 20;412(23-24):2248-53. doi: 10.1016/j.cca.2011.08.013. Epub 2011 Aug 16. Clin Chim Acta. 2011. PMID: 21864520

10

Influence of cortisol status on leptin secretion.

Leal-Cerro A, Soto A, Martínez MA, Dieguez C, Casanueva FF. Leal-Cerro A, et al. Pituitary. 2001 Jan-Apr;4(1-2):111-6. doi: 10.1023/a:1012903330944. Pituitary. 2001. PMID: 11824503 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page